Loading…
StoneX Group
NASDAQ: SNEX Financials Cap Markets 🔎 Screen
🏹 Trader: 💎 VCP Breakout View all →
$7.3B
Market Cap
17.1
P/E
0.83
PEG
ROCE
15.2%
ROE
0.05
D/E
OPM
-25.3%
% from 52W High
78
α RS
🔍 SNEX is showing a high-conviction setup because it matches 5 of 37 tracked screener presets, Sector RRG has Financials in the Improving quadrant with the trail still strengthening, and RS Rating is 78. Net: Broad signal stack, not a recommendation. ? Conviction RRG RS Rating
Sources
Conviction 5/37 · Financials in Improving quadrant · RS Rating 78
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for SNEX including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

StoneX Group Inc. operates as a global financial services network that connects companies, organizations, traders, and investors to a market ecosystem in the United States, Europe, South America, the Middle East, Asia, and internationally.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding SNEX
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 8.1K $651K 0.00% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED StoneX reports record Q2 FY2026: net income $174.3M, EPS $2.07, ROE 26.5%.
Revenue & Profitability
Net income for Q2 FY2026 was a record $174.3 million, up 143% year-over-year. Diluted EPS was $2.07 (split-adjusted), up 120%. Net operating revenues rose 70% year-over-year to $1.6 billion. Operating revenues (including interest) were $1.6 billion, up 64%. Segment highlights: Commercial segment net operating revenues up 111%, Institutional up 65%, Self-directed retail up 15%, Payments up 10%. Net income for the trailing twelve months was a record $462.4 million, with EPS of $5.60 and ROE of 19.8%.
Outlook
Management highlighted a more volatile economic backdrop driven by geopolitical uncertainty (e.g., U.S.-Iran conflict), which they believe plays into StoneX's strengths as volatility drives demand for their services. They noted continued engagement from institutional counterparties in cross-border payments and broad-based growth across products. However, they remain mindful that heightened volatility increases the risk of credit losses, though they work closely with clients to mitigate this.
Growth Drivers
Key growth drivers include: listed derivatives (volumes nearing 100 million contracts, average client equity ~$14 billion), OTC derivatives (record volumes >1.5 million contracts, up 68% YoY), physical contracts (record operating revenues, led by precious metals), securities (average daily volume >$12 billion), and payments (second-highest ADV of $92 million, up 19% YoY). The RJO integration is expanding scale and cross-sell opportunities. AI deployment is enhancing operational efficiency, with a focus on client support, settlement automation, and software development.
Balance Sheet & CapEx
Not discussed as a separate line item. However, management discussed strategic investments in AI, including AI-assisted automation for settlement instruction repair/validation, AI chatbots for client services, and agentic development support for programmers. These initiatives aim to speed up development, improve agility, and reduce manual intervention. The company continues to invest in proprietary electronic platforms and core architecture for market making and global expansion.
Margins
Not discussed with explicit margin percentages. However, management noted strong operating leverage in the self-directed retail segment (segment income up 40% on 15% revenue growth). Total fixed compensation and other expenses rose 44% year-over-year, partly due to acquisitions and higher employee benefits. Bad debt expense increased $12.3 million, mainly in the commercial segment. The company expects ongoing efficiency gains from RJO integration (target $50 million run-rate synergies by end of process) and from AI-driven automation.
Key Risks
Management flagged credit risk from heightened volatility; bad debt expense increased $12.3 million in the quarter, primarily in the commercial segment, though they noted losses were 'somewhat minimal' relative to the environment. Geopolitical uncertainty (e.g., U.S.-Iran conflict) creates both opportunities and risks. The company recently resolved several large-scale litigation matters (BTIG, OptionSellers, patent case), but legal fees remain a cost. Integration of RJO and related severance/retention costs were mentioned as near-term expense items.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q3 2026 Q3 2026 2026-08-06
Net operating revenues rose 47% year-over-year to $719.7M, with net income up 102% to $127.9M and EPS up 85%. Commercial and Institutional segments led growth, aided by RJO and Benchmark acquisitions. Strong client activity, technology investments, and disciplined M&A drive continued expansion.
Q2 2026 Q2 2026 2026-05-07
Record quarterly results with net income up 143% year-over-year, driven by strong growth across all segments and successful integration of R.J. O'Brien. Volatility and client demand fueled double-digit product growth, while cost synergies and AI initiatives enhanced efficiency.
Q1 2026 Q1 2026 2026-02-05
Record quarterly results driven by strong growth in listed derivatives, precious metals, and institutional segments, with significant contributions from the R.J. O'Brien acquisition. Integration and synergy targets remain on track, while digital expansion and new market entries support future growth.
Q4 2025 Q4 2025 2025-11-25
Record Q4 and FY25 results driven by strong growth in institutional and commercial segments, with significant contributions from the RJO acquisition. Integration is progressing well, with $20M in cost synergies realized and further benefits expected. Stable recurring income and robust capital management underpin a positive outlook for 2026.
Q3 2025 Q3 2025 2025-08-06
Q3 saw 2% net income growth and 12% revenue growth, with strong institutional and retail performance offsetting commercial segment weakness due to tariff and volatility impacts. RJO and Benchmark acquisitions closed, expected to be accretive to earnings and margins.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.